We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





AACC Launches COVID-19 Immunity Study at 2021 Annual Scientific Meeting and Clinical Lab Expo

By LabMedica International staff writers
Posted on 31 Aug 2021
Print article
Illustration
Illustration
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is launching the COVID-19 Immunity Study, which will examine immune responses to SARS-CoV-2 vaccination or prior infection in a diverse group of volunteers.

Despite continued efforts by the scientific community to understand all aspects of COVID-19, it is still not known how long the currently available SARS-CoV-2 vaccines can provide protection against the SARS-CoV-2 virus. In order to gain further insights into this issue, AACC’s study will also further examine the utility of serologic tests as a means to measure lasting immunity.

AACC will collect blood samples for the planned study from attendees and exhibitors at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo to be held in Atlanta on September 28-30. All study participants must be 18 years of age and efforts will be made to ensure that the research cohort is as diverse as possible. This approach to sample collection is modeled after AACC’s Universal Sample Bank program, which used samples from attendees of the 2015 AACC Annual Scientific Meeting in support of important research related to troponin. People who are unable to attend the meeting in person can also contribute to the study by submitting answers to a 10-minute COVID-19 health questionnaire. In return for donating blood, the study participants will receive the results of their individual antibody profile tests after all the collected samples have been analyzed.

Related Links:
American Association for Clinical Chemistry

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article
AACC

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.